Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered question first ministerially corrected answering member label attachment file name file name title title previous answer version answering member constituency answering member printed attachment file name file name title title answering member label
tabling member	label

Search

988900

	registered interest
	date	16/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Liverpool
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the ratio of GPs to patients was in each Liverpool parliamentary constituency in each of the past 10 years.
	tabling member constituency	Liverpool, Wavertree
	tabling member printed	Luciana Berger
	uin	180171
	answer	answer is ministerial correction date of answer 22/10/2018 answer text <p>The ratio of patients per general practitioner is provided in the table attached. Figures are not available at a parliamentary constituency level; therefore figures have been included at the lowest available level corresponding to these areas, specifically primary care trusts prior to 2013, and clinical commissioning groups from 2013 onwards.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 22/10/2018 16:19:20 question first ministerially corrected 23/10/2018 09:15:31 answering member 4067 label Biography information for Steve Brine attachment 1 file name table PQ180171.docx title GP to patient ratio previous answer version 79964 answering member constituency Winchester answering member printed Steve Brine answering member 4067 label Biography information for Steve Brine
	tabling member	4036 label Biography information for Luciana Berger

176781

	registered interest
	date	29/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether joint committees of NHS England and clinical commissioning groups are permitted to deviate from national service specifications for specialised services.
	tabling member constituency	Walsall South
	tabling member printed	Valerie Vaz
	uin	222695
	answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England is the accountable commissioner and budget holder for all specialised services as set out in The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the Manual for prescribed specialised services providing further detail.</p><p> </p><p> </p><p> </p><p>NHS England has achieved significant progress in developing a set of nationally consistent service standards and commissioning policies, which ensure equity of access to high quality services across the board. Those standards and policies will continue to apply for those specialised services which are to be collaboratively commissioned by NHS England and clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England is currently in the process of agreeing the guidance on the collaborative commissioning arrangements which will be in place from 1 April 2015.</p><p> </p><p> </p><p> </p><p>NHS England has clarified that where there are collaboratively commissioned services, NHS England will retain the full financial risk for these services for 2015/16. NHS England has advised us that there will be further work conducted over the next year to advise on the range of specialised services for which NHS England should remain the accountable commissioner and budget holder for 2016/17 and future years.</p><p> </p><p> </p><p> </p><p>Copies of The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 and the Manual for prescribed specialised services are attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison attachment 1 file name nhs-england-and-ccg-regulations.pdf title Regulations NHS Commissioning Board & CCGs 2 file name pss-manual.pdf title Manual prescribed specialised services question first answered 03/02/2015 15:09:14 question first ministerially corrected 03/02/2015 15:20:37 answering member 3918 label Biography information for Jane Ellison previous answer version 42619 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	4076 label Biography information for Valerie Vaz

176783

	registered interest
	date	29/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, when NHS England will publish details of the co-commissioning of specialised services.
	tabling member constituency	Walsall South
	tabling member printed	Valerie Vaz
	uin	222693
	answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England is the accountable commissioner and budget holder for all specialised services as set out in The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the Manual for prescribed specialised services providing further detail.</p><p> </p><p> </p><p> </p><p>NHS England has achieved significant progress in developing a set of nationally consistent service standards and commissioning policies, which ensure equity of access to high quality services across the board. Those standards and policies will continue to apply for those specialised services which are to be collaboratively commissioned by NHS England and clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England is currently in the process of agreeing the guidance on the collaborative commissioning arrangements which will be in place from 1 April 2015.</p><p> </p><p> </p><p> </p><p>NHS England has clarified that where there are collaboratively commissioned services, NHS England will retain the full financial risk for these services for 2015/16. NHS England has advised us that there will be further work conducted over the next year to advise on the range of specialised services for which NHS England should remain the accountable commissioner and budget holder for 2016/17 and future years.</p><p> </p><p> </p><p> </p><p>Copies of The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 and the Manual for prescribed specialised services are attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison attachment 1 file name nhs-england-and-ccg-regulations.pdf title Regulations NHS Commissioning Board & CCGs 2 file name pss-manual.pdf title Manual prescribed specialised services question first answered 03/02/2015 15:09:14 question first ministerially corrected 03/02/2015 15:21:10 answering member 3918 label Biography information for Jane Ellison previous answer version 42620 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	4076 label Biography information for Valerie Vaz

176784

	registered interest
	date	29/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, whether NHS England will remain the sole budget-holder and accountable commissioner for all specialised services.
	tabling member constituency	Walsall South
	tabling member printed	Valerie Vaz
	uin	222694
	answer	answer is ministerial correction date of answer 03/02/2015 answer text <p>NHS England is the accountable commissioner and budget holder for all specialised services as set out in The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, with the Manual for prescribed specialised services providing further detail.</p><p> </p><p> </p><p> </p><p>NHS England has achieved significant progress in developing a set of nationally consistent service standards and commissioning policies, which ensure equity of access to high quality services across the board. Those standards and policies will continue to apply for those specialised services which are to be collaboratively commissioned by NHS England and clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England is currently in the process of agreeing the guidance on the collaborative commissioning arrangements which will be in place from 1 April 2015.</p><p> </p><p> </p><p> </p><p>NHS England has clarified that where there are collaboratively commissioned services, NHS England will retain the full financial risk for these services for 2015/16. NHS England has advised us that there will be further work conducted over the next year to advise on the range of specialised services for which NHS England should remain the accountable commissioner and budget holder for 2016/17 and future years.</p><p> </p><p> </p><p> </p><p>Copies of The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 and the Manual for prescribed specialised services are attached.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison attachment 1 file name nhs-england-and-ccg-regulations.pdf title Regulations NHS Commissioning Board & CCGs 2 file name pss-manual.pdf title Manual prescribed specialised services question first answered 03/02/2015 15:09:14 question first ministerially corrected 03/02/2015 15:23:29 answering member 3918 label Biography information for Jane Ellison previous answer version 42621 answering member constituency Battersea answering member printed Jane Ellison answering member 3918 label Biography information for Jane Ellison
	tabling member	4076 label Biography information for Valerie Vaz

1362396

	registered interest
	date	21/10/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Oral Tobacco
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government why they maintain a ban on snus products.
	tabling member printed	Lord Jones of Cheltenham
	uin	HL3286
	answer	answer is ministerial correction date of answer 15/11/2021 answer text <p>Consumption of any tobacco product is harmful and it is the Government’s policy to support people to quit all forms of tobacco use. Oral tobacco, or snus, is banned in the United Kingdom under the Tobacco and Related Products Regulations 2016.</p><p>There is limited data on the health risks posed to smokers who switch to snus products. Evidence submitted on snus to the United States Food and Drug Administration states that there are still health risks involved with the use of snus. Although snus products contain significantly lower levels of harmful carcinogens than other smokeless tobacco products, the products contain nitrosamines, including NNN and NNK, which have been demonstrated to cause cancer, including cancers of the mouth. A copy of this evidence, <em>Modified Risk Tobacco Product (MRTP) ApplicationTechnical Project Lead (TPL) Review</em>, is attached.</p><p><em>Health risks of Scandinavian snus consumption (English summary)</em> from Norway shows that tobacco products such as oral tobacco contains carcinogenic substances which are associated with a number of adverse health effects. This is regardless of whether the individual is a smoker or not. A copy of this summary is attached.</p> answering member printed Lord Kamall attachment 1 file name health-risks-of-scandinavian-snus-consumption-english-summary-pdf.pdf title Health risks of Scandinavian snus consumption 2 file name SMUSA-TPL-Review.pdf title Modified Risk Tobacco Product Application (MRTPA) question first answered 15/11/2021 11:48:11 question first ministerially corrected 16/12/2021 13:06:49 answering member 4909 label Biography information for Lord Kamall previous answer version 31942 answering member printed Lord Kamall attachment 1 file name health-risks-of-scandinavian-snus-consumption-english-summary-pdf.pdf title Health risks of Scandinavian snus consumption 2 file name Modified-Risk-Tobacco-Product-Application-Technical-Project-Lead-Review-Swedish-Match-North-America.pdf title Modified Risk Tobacco Product (MRTP) ApplicationTe answering member 4909 label Biography information for Lord Kamall
	tabling member	248 label Biography information for Lord Jones of Cheltenham

1362397

	registered interest
	date	21/10/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Oral Tobacco: Health Hazards
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what evidence that they have, if any, which identifies the health risks posed to smokers who switch to snus products.
	tabling member printed	Lord Jones of Cheltenham
	uin	HL3287
	answer	answer is ministerial correction date of answer 15/11/2021 answer text <p>Consumption of any tobacco product is harmful and it is the Government’s policy to support people to quit all forms of tobacco use. Oral tobacco, or snus, is banned in the United Kingdom under the Tobacco and Related Products Regulations 2016.</p><p>There is limited data on the health risks posed to smokers who switch to snus products. Evidence submitted on snus to the United States Food and Drug Administration states that there are still health risks involved with the use of snus. Although snus products contain significantly lower levels of harmful carcinogens than other smokeless tobacco products, the products contain nitrosamines, including NNN and NNK, which have been demonstrated to cause cancer, including cancers of the mouth. A copy of this evidence, <em>Modified Risk Tobacco Product (MRTP) ApplicationTechnical Project Lead (TPL) Review</em>, is attached.</p><p><em>Health risks of Scandinavian snus consumption (English summary)</em> from Norway shows that tobacco products such as oral tobacco contains carcinogenic substances which are associated with a number of adverse health effects. This is regardless of whether the individual is a smoker or not. A copy of this summary is attached.</p> answering member printed Lord Kamall attachment 1 file name health-risks-of-scandinavian-snus-consumption-english-summary-pdf.pdf title Health risks of Scandinavian snus consumption 2 file name SMUSA-TPL-Review.pdf title Modified Risk Tobacco Product Application (MRTPA) question first answered 15/11/2021 11:48:11 question first ministerially corrected 16/12/2021 12:18:50 answering member 4909 label Biography information for Lord Kamall previous answer version 31943 answering member printed Lord Kamall attachment 1 file name health-risks-of-scandinavian-snus-consumption-english-summary-pdf.pdf title Health risks of Scandinavian snus consumption 2 file name Modified-Risk-Tobacco-Product-Application-Technical-Project-Lead-Review-Swedish-Match-North-America.pdf title Modified Risk Tobacco Product (MRTP) ApplicationTe answering member 4909 label Biography information for Lord Kamall
	tabling member	248 label Biography information for Lord Jones of Cheltenham

390599

	registered interest
	date	16/07/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Anaemia
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what action they are taking to address the problems associated with the late diagnosis of pernicious anaemia, in the light of the results of the survey published in the <i>British Nursing Journal</i> in April 2014.
	tabling member printed	The Countess of Mar
	uin	HL1539
	answer	answer is ministerial correction date of answer 24/07/2015 answer text <p>It is important that patients suffering from pernicious anaemia, the result of a vitamin B12 (cobalamin) deficiency, receive a prompt and appropriate diagnosis. Pernicious anaemia develops gradually, and can cause a range of symptoms, including fatigue, lethargy, feeling faint and headaches, which vary from patient to patient. Because of the gradual progression of the condition, the variety of symptoms, which are shared with a range of other conditions, diagnosis at early onset can be challenging.</p><p>To support the diagnosis of pernicious anaemia, the British Committee for Standards in Haematology (BCSH) has published <em>Guidelines for the diagnosis and treatment of Cobalamin and Folate disorders,</em> which sets out that cobalamin status is the recommended first line diagnostic test. However, the guidance states that there is no gold standard test for the condition and makes it clear that the clinical picture of a patient is the most important factor in assessing the significance of the test results. This means clinicians should take into account all of the symptoms the patent is experiencing, their medical history, age and other relevant factors when considering the implications of a patient’s cobalamin status. The BCSH guidance highlights the risk of neurological impairment if treatment is delayed.</p><p><br /> The BCSH operates independently of Department and NHS England and produces evidence based guidelines for both clinical and laboratory haematologists on the diagnosis and treatment of haematological disease, drawing on the advice of expert consultants and clinical scientists practicing in the United Kingdom. It would be for the BCSH, not the Department, to consider whether any adjustments to current best practice in the diagnosis and treatment of patients with pernicious anaemia were needed, including whether any new or additional tests were appropriate. A copy of the BCSH guidance document <del class="ministerial">has already been placed in the Library and</del> is attached.</p><p><br /> More general clinical guidance on the diagnosis and management of pernicious anaemia can also be found on the National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summaries website. This is a freely accessible online resource that covers the causes, symptoms, diagnosis and treatment of pernicious anaemia, as well as potential complications of the condition. In addition to this, NHS Choices provides similar, though less technical, information on pernicious anaemia for the public.</p> answering member printed Lord Prior of Brampton question first answered 24/07/2015 13:21:19 question first ministerially corrected 14/10/2015 11:21:08 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name colbalamin and folate disorders.pdf title BCSH Guidelines pernicious anaemia previous answer version 17459 answering member printed Lord Prior of Brampton answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name colbalamin and folate disorders.pdf title BCSH Guidelines pernicious anaemia
	tabling member	1861 label Biography information for The Countess of Mar

390600

	registered interest
	date	16/07/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Anaemia
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government how they propose to alert medical practitioners to the severe and irreversible nerve damage that can occur when pernicious anaemia is misdiagnosed.
	tabling member printed	The Countess of Mar
	uin	HL1540
	answer	answer is ministerial correction date of answer 24/07/2015 answer text <p>It is important that patients suffering from pernicious anaemia, the result of a vitamin B12 (cobalamin) deficiency, receive a prompt and appropriate diagnosis. Pernicious anaemia develops gradually, and can cause a range of symptoms, including fatigue, lethargy, feeling faint and headaches, which vary from patient to patient. Because of the gradual progression of the condition, the variety of symptoms, which are shared with a range of other conditions, diagnosis at early onset can be challenging.</p><p>To support the diagnosis of pernicious anaemia, the British Committee for Standards in Haematology (BCSH) has published <em>Guidelines for the diagnosis and treatment of Cobalamin and Folate disorders,</em> which sets out that cobalamin status is the recommended first line diagnostic test. However, the guidance states that there is no gold standard test for the condition and makes it clear that the clinical picture of a patient is the most important factor in assessing the significance of the test results. This means clinicians should take into account all of the symptoms the patent is experiencing, their medical history, age and other relevant factors when considering the implications of a patient’s cobalamin status. The BCSH guidance highlights the risk of neurological impairment if treatment is delayed.</p><p><br /> The BCSH operates independently of Department and NHS England and produces evidence based guidelines for both clinical and laboratory haematologists on the diagnosis and treatment of haematological disease, drawing on the advice of expert consultants and clinical scientists practicing in the United Kingdom. It would be for the BCSH, not the Department, to consider whether any adjustments to current best practice in the diagnosis and treatment of patients with pernicious anaemia were needed, including whether any new or additional tests were appropriate. A copy of the BCSH guidance document <del class="ministerial">has already been placed in the Library and</del> is attached.</p><p><br /> More general clinical guidance on the diagnosis and management of pernicious anaemia can also be found on the National Institute for Health and Care Excellence (NICE) Clinical Knowledge Summaries website. This is a freely accessible online resource that covers the causes, symptoms, diagnosis and treatment of pernicious anaemia, as well as potential complications of the condition. In addition to this, NHS Choices provides similar, though less technical, information on pernicious anaemia for the public.</p> answering member printed Lord Prior of Brampton question first answered 24/07/2015 13:21:19 question first ministerially corrected 14/10/2015 11:21:19 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name colbalamin and folate disorders.pdf title BCSH Guidelines pernicious anaemia previous answer version 17460 answering member printed Lord Prior of Brampton answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name colbalamin and folate disorders.pdf title BCSH Guidelines pernicious anaemia
	tabling member	1861 label Biography information for The Countess of Mar

1307874

	registered interest
	date	12/04/2021
	answering body	Department for International Trade
	answering dept id	202
	answering dept short name	International Trade
	answering dept sort name	International Trade
	hansard heading	Members: Correspondence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for International Trade, when she plans to respond to the letter dated 12 February 2021 from the hon. Member for West Lancashire, reference ZA55555, regarding delays to international purchasing and business imports.
	tabling member constituency	West Lancashire
	tabling member printed	Rosie Cooper
	uin	178947
	answer	answer is ministerial correction date of answer 19/04/2021 answer text <p>The Department for International Trade’s correspondence team has transferred your letter to the Cabinet Office for a response as the subject of the letter sits within their portfolio.</p> answering member constituency Chelsea and Fulham answering member printed Greg Hands question first answered 19/04/2021 10:23:06 question first ministerially corrected 19/04/2021 13:50:47 answering member 1526 label Biography information for Greg Hands attachment 1 file name ZA55555 to DfIT.pdf title Rosie Cooper's letter to Liz Truss previous answer version 96794 answering member constituency Chelsea and Fulham answering member printed Greg Hands answering member 1526 label Biography information for Greg Hands
	tabling member	1538 label Biography information for Rosie Cooper

439412

	registered interest
	date	17/12/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	General Practitioners: Northamptonshire
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how many practising GPs there were in Northamptonshire in (a) 2005, (b) 2010 and (c) 2015.
	tabling member constituency	Kettering
	tabling member printed	Mr Philip Hollobone
	uin	20613
	answer	answer is ministerial correction date of answer 05/01/2016 answer text <p>Data is not available in the format requested. 2014 is the most recent year for which data is available. The attached tables show the number of practising general practitioners (GPs), both including and excluding retainers and registrars, in Northamptonshire in 2005, 2010 and 2014.</p> answering member constituency North East Bedfordshire answering member printed Alistair Burt question first answered 05/01/2016 15:36:52 question first ministerially corrected 25/01/2016 15:52:55 answering member 1201 label Biography information for Alistair Burt attachment 1 file name Written_PQ20613 - Phillip Hollobone tables.docx title GPs numbers Northamptonshire previous answer version 37559 answering member constituency North East Bedfordshire answering member printed Alistair Burt answering member 1201 label Biography information for Alistair Burt
	tabling member	1537 label Biography information for Mr Philip Hollobone